Clinical Trial Update: To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of ZKY001 Eye Drops for corneal epithelial defects caused by neurotrophic keratitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Epithelial Defect
• Neurotrophic Keratitis

Drugs mentioned

• ZKY001 Eye Drops

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Corneal Epithelial Defect | Phase 2 | Status: COMPLETED